Monitor Kidney Function in Patients Starting an SGLT2 Inhibitor
August 2016
You'll hear debate over whether SGLT2 inhibitors (Jardiance, etc) harm or help the kidneys in type 2 diabetes patients.
New warnings suggest that canagliflozin (Invokana, etc.) or dapagliflozin (Farxiga, etc.) can cause acute kidney INJURY. But other recent evidence suggests the SGLT2 inhibitors, or "flozins," may be PROTECTIVE.
For example, flozins can increase serum creatinine (SCr)...usually within the first month. This is likely due to their diuretic effect...and more common in patients with dehydration, poor renal function, or on an NSAID, diuretic, ACEI, or ARB.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote